Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Hoda E. Sayegh"'
Autor:
Hoda E. Sayegh, Kayla M. Daniell, Fangdi Sun, Dejan Juric, Cheryl L. Brunelle, Steven J. Isakoff, Donna M. Fitzgerald, George E. Naoum, Sacha A. Roberts, Aditya Bardia, Tessa C Gillespie, Alphonse G. Taghian
Publikováno v:
Breast Cancer Research and Treatment. 175:649-658
This study evaluated development of edema in patients receiving PI3K/mTOR/CDK4/6 targeted therapy for metastatic breast cancer (MBC). We reviewed medical records of 160 patients receiving targeted therapy with PI3K/mTOR/CDK4/6 inhibitors to treat MBC
Autor:
Kayla M. Daniell, Fangdi Sun, Tessa C Gillespie, Aditya Bardia, SJ Isakoff, Cheryl L. Brunelle, Dejan Juric, Hoda E. Sayegh, Alphonse G. Taghian, George E. Naoum
Publikováno v:
Cancer Research. 79:P3-14
Background: Targeted therapies, including mTOR and CDK 4/6 inhibitors, have changed the landscape of management of hormone receptor-positive (HR+) metastatic breast cancer (MBC). These therapies have shown significant improvement in progression-free
Autor:
Peter H.R. Green, Cezary Ciszewski, Bana Jabri, Dustin G. Shaw, Ian Lawrence, Vinod Kumar, Carol E. Semrad, Herman Gudjonson, Hilary Jericho, Jamie Rossjohn, Toufic Mayassi, Ranjana Gokhale, Mai T. Tran, Hoda E. Sayegh, Aaron R. Dinner, Jean-Christophe Grenier, Sonia S. Kupfer, Vincent van Unen, James E. McLaren, Kristin Ladell, Cisca Wijmenga, Matthew Dimaano, David Price, Jagoda Rokicka, Stefano Guandalini, Luis B. Barreiro, Hugh H. Reid
Publikováno v:
Cell, 176, 5, pp. 967-981.e19
Cell, 176(5), 967-981,e19. CELL PRESS
Cell, 176, 967-981.e19
Cell, 176(5), 967-981,e19. CELL PRESS
Cell, 176, 967-981.e19
Contains fulltext : 215586.pdf (Publisher’s version ) (Open Access) Tissue-resident lymphocytes play a key role in immune surveillance, but it remains unclear how these inherently stable cell populations respond to chronic inflammation. In the sett
Autor:
Hoda E. Sayegh, Meyha N. Swaroop, Amir I. Mina, George E. Naoum, Melissa N. Skolny, Kayla M. Daniell, Tessa C Gillespie, Laura Salama, Susan G.R. McDuff, Maria S. Asdourian, Laura E.G. Warren, Hui Zheng, Cheryl L. Brunelle, Mohamed Abouegylah, Alphonse G. Taghian
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 103:62-70
Purpose The purpose of the study was to determine when the risk of lymphedema is highest after treatment of breast cancer and which factors influence the time course of lymphedema development. Methods and Materials Between 2005 and 2017, 2171 women (
Autor:
Lior Z. Braunstein, Brian Napolitano, Tessa C Gillespie, Mohamed Abouegylah, Alphonse G. Taghian, Mohamed Farouk, Laura Salama, K. Remillard, Abdelsalam A. Ismail, Andrzej Niemierko, Steve Edgington, George E. Naoum, Hoda E. Sayegh, Mohamed A. Alm El-Din, Mostafa Elebrashi
Publikováno v:
Breast Cancer Res Treat
PURPOSE: Patients with Her2-positive breast cancer treated with trastuzumab have higher rates of cardiotoxicity (CT). Left-breast radiation might increase the risk for CT from cardiac exposure to radiation. The goal of our study is to evaluate the co
Autor:
Tessa C Gillespie, Alphonse G. Taghian, Cheryl L. Brunelle, Megan P Tighe, Alexander M J Hall, Fangdi Sun, Kayla M. Daniell, Hoda E. Sayegh
Publikováno v:
Breast Cancer Research and Treatment. 172:83-91
PURPOSE: Despite increasing emphasis on screening and early intervention for breast cancer-related lymphedema (BCRL), there is marked heterogeneity in diagnostic methodology, including for volumetric measures. This retrospective study compared two vo
Autor:
Dhruv Singhal, Simona F. Shaitelman, Hoda E. Sayegh, Alphonse G. Taghian, Andrea V. Barrio, Cheryl L. Brunelle
Publikováno v:
Physical Therapy. 98:277-281
Autor:
Cheryl L. Brunelle, Meyha N. Swaroop, Melissa N. Skolny, Hui Zheng, Maria S. Asdourian, Amir I. Mina, Hoda E. Sayegh, Alphonse G. Taghian
Publikováno v:
Journal of Clinical Oncology. 35:3934-3941
Purpose This study examined the lifestyle and clinical risk factors for lymphedema in a cohort of patients who underwent bilateral breast cancer surgery. Patients and Methods Between 2013 and 2016, 327 patients who underwent bilateral breast cancer s
Autor:
Gelila Goba, Joel Schwartz, Nicole Lugo Santiago, Shannon MacLaughlan David, Richard E. Barrett, Kimberly A. Kim, Hoda E. Sayegh, Divya Singh, Bani Medegan Fagla
Publikováno v:
Gynecologic Oncology. 159:e28-e29
Publikováno v:
Gland surgery. 7(4)
Breast cancer-related lymphedema (BCRL) is a negative sequela of breast cancer treatment, and well-established risk factors include axillary lymph node dissection (ALND) and regional lymph node radiation (RLNR). BCRL affects approximately 1 in 5 pati